Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial-Reference-Cited by-同舟云学术

Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial

Published:2021-08-18 Issue:10 Volume:62 Page:2505-2517
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Scheffer Ingrid E.¹^ORCID,Halford Jonathan J.²^ORCID,Miller Ian³^ORCID,Nabbout Rima⁴,Sanchez‐Carpintero Rocio⁵^ORCID,Shiloh‐Malawsky Yael⁶,Wong Matthew⁷,Zolnowska Marta⁸,Checketts Daniel⁹,Dunayevich Eduardo¹⁰,Devinsky Orrin¹¹^ORCID

Affiliation:

1. University of Melbourne, Austin Health Heidelberg Victoria Australia

2. Medical University of South Carolina Charleston South Carolina USA

3. Nicklaus Children's Hospital Miami Florida USA

4. Necker Enfants Malades Hospital Imagine Institute University of Paris Paris France

5. Pediatric Neurology Unit Pamplona Spain

6. University of North Carolina at Chapel Hill Chapel Hill North Carolina USA

7. Wake Forest School of Medicine Winston‐Salem North Carolina USA

8. Medical Center Pleiades Krakow Poland

9. GW Research Cambridge United Kingdom

10. Greenwich Biosciences Carlsbad California USA

11. NYU Langone Comprehensive Epilepsy Center New York New York USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17036

Reference14 articles.

1. International League Against Epilepsy.Dravet syndrome: clinical overview.2019.https://www.epilepsydiagnosis.org/syndrome/dravet‐overview.html. Accessed 22 Mar 2021.

2. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome

3. Mortality in Dravet syndrome

4. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid treatments in epilepsy and seizure disorders;Physiological Reviews;2024-04-01

2. Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey;Epilepsy Research;2024-02

3. Development of cannabidiol derivatives as potent broad-spectrum antibacterial agents with membrane-disruptive mechanism;European Journal of Medicinal Chemistry;2024-02

4. Pathophysiology to Risk Factor and Therapeutics to Treatment Strategies on Epilepsy;Brain Sciences;2024-01-10

5. Real-Life Experience With Purified Cannabidiol Treatment for Refractory Epilepsy: A Multicenter Retrospective Study;Pediatric Neurology;2024-01